Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Do inhaled anticholinergics in...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Do inhaled anticholinergics increase the risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease?
Bibliographic Details
Main Authors:
Prieto Alhambra, D
,
Don, M
,
Galán Aisa, A
,
Castillo, D
,
Martín Cantera, C
Format:
Journal article
Language:
Spanish; Castilian
Published:
2009
Holdings
Description
Similar Items
Staff View
Similar Items
Cardiovascular Events According to Inhaler Therapy and Comorbidities in Chronic Obstructive Pulmonary Disease
by: Kim EK, et al.
Published: (2024-01-01)
Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD.
by: McNicholas, W, et al.
Published: (2004)
PHARMACOECONOMIC STUDY OVER USE OF ANTICHOLINERGIC BRONCHODILATORS (SPIRIVA AND ATROVENT) FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: A. U. Kulikov, et al.
Published: (2015-03-01)
An evaluation of the use of inhalers in asthma and chronic obstructive pulmonary disease
by: Seçil Çakmaklı, M.D., et al.
Published: (2023-08-01)
Prediabetes as a risk factor for major adverse cardiovascular events
by: Ramy Mando, et al.
Published: (2021-01-01)